Items where authors include "Gallagher, F.A."

Article

Rossi, S.H., Choueiri, T.K., Jewett, M. orcid.org/0000-0001-7162-5380 et al. (84 more authors) (2025) What is required to deliver practice-changing neoadjuvant trials in kidney cancer? An international neoadjuvant kidney cancer consortium Delphi study. Annals of Oncology. ISSN 0923-7534

Coen, O., Corrie, P., Marshall, H. et al. (17 more authors) (2021) The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma. BMC Cancer, 21 (1). 761. ISSN 1471-2407

O'Connor, J.P.B., Aboagye, E.O., Adams, J.E. et al. (74 more authors) (2017) Imaging biomarker roadmap for cancer studies. Nature Reviews Clinical Oncology, 14. pp. 169-186. ISSN 1759-4774

Proceedings Paper

Danson, S., Collinson, M., Plummer, E.R. et al. (17 more authors) (2025) Comparison of 1 year versus minimum 2 years of anti-PD1-based immunotherapy as first-line treatment for metastatic melanoma: Results of the DANTE phase III trial. In: Journal of Clinical Oncology. 2025 ASCO Annual Meeting II, 30 May - 03 Jun 2025, Chicago, USA. American Society of Clinical Oncology (ASCO) .